Detailed Information on Publication Record
2007
A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ et. al.Basic information
Original name
A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
Name in Czech
Modelování počtu potenciálně léčených onkologických pacientů v ČR
Name (in English)
A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
Authors
DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ, Jitka ABRAHÁMOVÁ, Rostislav VYZULA and Jiří VORLÍČEK
Edition
TIES 2007, 2007
Other information
Language
Czech
Type of outcome
Prezentace na konferencích
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Organization unit
Faculty of Medicine
ISBN
978-80-210-4333-6
Keywords in English
modelling; cancer prevalence; cancer survival; cancer incidence
Změněno: 30/6/2008 12:43, RNDr. Tomáš Pavlík, Ph.D.
V originále
The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.
In English
The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.